ES2530751T3 - Tobramycin formulation - Google Patents
Tobramycin formulation Download PDFInfo
- Publication number
- ES2530751T3 ES2530751T3 ES13002039T ES13002039T ES2530751T3 ES 2530751 T3 ES2530751 T3 ES 2530751T3 ES 13002039 T ES13002039 T ES 13002039T ES 13002039 T ES13002039 T ES 13002039T ES 2530751 T3 ES2530751 T3 ES 2530751T3
- Authority
- ES
- Spain
- Prior art keywords
- formulation
- tobramycin formulation
- tobramycin
- mosmol
- osmolality
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 title abstract 2
- 229960000707 tobramycin Drugs 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000003186 pharmaceutical solution Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229910001868 water Inorganic materials 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una formulación de disolución farmacéutica que comprende tobramicina, agua, cloruro sódico y citrato sódico, en la que la formulación tiene un pH de 4,5-7,0 y una osmolalidad de 135-200 mOsmol/Kg.A pharmaceutical solution formulation comprising tobramycin, water, sodium chloride and sodium citrate, in which the formulation has a pH of 4.5-7.0 and an osmolality of 135-200 mOsmol / Kg.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261644700P | 2012-05-09 | 2012-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2530751T3 true ES2530751T3 (en) | 2015-03-05 |
Family
ID=52594985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13002039T Active ES2530751T3 (en) | 2012-05-09 | 2013-04-18 | Tobramycin formulation |
Country Status (5)
| Country | Link |
|---|---|
| CY (1) | CY1116053T1 (en) |
| ES (1) | ES2530751T3 (en) |
| HR (1) | HRP20150085T1 (en) |
| RS (1) | RS53878B1 (en) |
| SI (1) | SI2662093T1 (en) |
-
2013
- 2013-04-18 SI SI201330018T patent/SI2662093T1/en unknown
- 2013-04-18 ES ES13002039T patent/ES2530751T3/en active Active
- 2013-04-18 RS RS20150059A patent/RS53878B1/en unknown
-
2015
- 2015-01-22 HR HRP20150085TT patent/HRP20150085T1/en unknown
- 2015-02-05 CY CY20151100118T patent/CY1116053T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2662093T1 (en) | 2015-06-30 |
| RS53878B1 (en) | 2015-08-31 |
| HRP20150085T1 (en) | 2015-05-08 |
| CY1116053T1 (en) | 2017-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160527A1 (en) | IMPROVED ADENOVIRUS FORMULATIONS | |
| BR112018075140A2 (en) | composition in the form of an injectable aqueous solution, and single dose formulation at a pH of 7 to 7.8 | |
| CL2014002258A1 (en) | Antibodies directed against matrix 9 metalloproteinases (mmp9 gelatinase b); pharmaceutical composition that contains it; and its uses | |
| AR098168A1 (en) | STABLE FORMULATION OF GLULISINE INSULIN | |
| AU339376S (en) | Sterilizing case | |
| CL2015000574A1 (en) | Stable aqueous formulations of adalimumab. | |
| DOP2016000298A (en) | PIRAZOLOPIRIDINAS AND PIRAZOLOPIRIMIDINAS | |
| CL2014003332A1 (en) | A composition comprising a solid water insoluble pesticide, a water soluble pesticide, a rheological agent and a wetting-dispersing agent. | |
| CL2014003148A1 (en) | Aqueous pharmaceutical composition containing a biological therapeutic agent and guanidine or a guanidine derivative and an injection that includes the composition. | |
| UY35988A (en) | PROCESS FOR THE PRODUCTION OF AN INJECTABLE LOW CONCENTRATION NORADRENALINE SOLUTION | |
| CO7200278A2 (en) | Solid pharmaceutical preparation containing levothyroxine | |
| CL2014002414A1 (en) | Injectable pharmaceutical composition comprising ibuprofen, an aqueous solution and a solubilizing agent selected from sodium phosphates, potassium, sodium carbonates, potassium carbonates and / or combinations thereof. | |
| UA115373C2 (en) | AMG 416 (VELCALSETID) STABLE LIQUID COMPOSITION | |
| CR20150310A (en) | SOLUTION TO PRESERVE VASCULAR DUCTS | |
| BR112015008389A2 (en) | compounds useful in the synthesis of benzamide compounds | |
| AR106559A1 (en) | WATERPROOF SUSPENSION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARATION | |
| UY34796A (en) | TOBRAMYCIN FORMULATION | |
| PY1361141A (en) | TEMPERATURE-STABLE AQUEOUS COMPOSITIONS OF CLOQUINTOCETMEXIL | |
| CL2016002792A1 (en) | Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed | |
| MX2015005734A (en) | METHODS OF TREATMENT OF HEPATIC DISEASES. | |
| UY34552A (en) | CRYSTAL FORM DELTA OF THE ARGININE SALT OF PERINDOPRILE, ITS PREPARATION PROCEDURE, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| AR098513A1 (en) | DENTROPHIC DISPENSER AND ORAL CARE SYSTEM THAT INCLUDES THE SAME | |
| CO2020008319A2 (en) | Methods to treat gaucher disease | |
| PE20160915A1 (en) | IMPROVED GELATINE COMPOSITION | |
| FR3014874B1 (en) | WATER-SOLUBLE THICKENING AGENT FOR AQUEOUS SYSTEMS, FORMULATIONS CONTAINING THE SAME AND USES THEREOF |